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Purpose: After excimer laser surgery, epidermal growth factor (EGF) plays an important role in injured corneal epithelial
cell on myofibroblastic cell formation in corneal stroma. The purpose of the study is to investigate the precise mechanism
of EGF on corneal wound healing, particularly on epithelial proliferation and migration.
Methods: In this study we applied small interference RNA (siRNA) to knock down the expression of eukaryotic translation
initiation  factor  5A  (eIF5A)  in  corneal  epithelial  cells.  The  relative  mRNA  and  protein  expression  of  matrix
metallopeptidase 9 (MMP9) and proliferating cell nuclear antigen (PCNA) was determined via real-time PCR and western
blot analysis. The proliferative potential of EGF was evaluated via a proliferation assay using the measurement of 3H-
thymidine incorporation (3H-TdR). HCEpiC apoptosis was subjected to flow cytometric analysis.
Results: The results showed eIF5A expression was enhanced and there was a statistically significant increase in EGF
treatment compared to the control group. Real-time PCR, western blot analysis, and the proliferation assay demonstrated
significantly lower MMP9 and PCNA expression and proliferation cell counts in eIF5A siRNA-treated groups versus
significantly higher levels in EGF plus eIF5A siRNA-treated groups. The data analysis showed that eIF5A, MMP9, and
PCNA expression decreased as a result of the inhibitor LY294002. Apoptotic cells were increased in the EGF plus
eIF5A siRNA, EGF plus LY294002, and EGF plus eIF5A siRNA plus LY294002 groups as compared with the EGF
siRNA group.
Conclusions:  These  results  indicate  that  EGF-induced  upregulation  of  eIF5A  stimulates  corneal  epithelial  cell
proliferation in vitro. EGF stimulation of corneal epithelial proliferation was through the phosphatidylinositol 3-kinase
(PI3-k)/protein kinase B (Akt) signaling pathway.
Photorefractive keratectomy (PRK) can result in tissue
ablation with a high degree of precision and minimal damage
to  the  adjacent  tissues,  and  this  has  become  a  favored
operation  to  correct  refractive  errors,  including  myopia,
hyperopia, and astigmatism [1]. The operation is effective and
safe,  but  some  patients  develop  a  postoperative  wound-
healing response, causing visual impairment.
The first stage of wound healing in the cornea after PRK
is epithelial migration. The maintenance of the normal corneal
epithelial thickness and its protective function depends on a
balance between the basal layer cell proliferation at a rate
adequate  to  replace  terminally  differentiated  cells  in  the
superficial layers [2]. In a variety of studies, growth factors
have been identified to be involved in maintaining epithelial
renewal  or  epithelial  cell  proliferation.  In  particular,
epidermal growth factor (EGF) is a substantive contribution
involved in this renewal process through its role in stimulating
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proliferation and differentiation [3]. An optimal dose of EGF
present in the medium can repair the wound of the corneal
epithelial cells at an enhanced rate. EGF stimulates wound
healing in vitro by a myriad of methods. One of the events in
these cascades includes the inactivation of apoptotic factors,
which in turn triggers proliferation in corneal epithelial cells
[4].
Eukaryotic  translation  initiation  factor  5A  (eIF5A)  is
highly conserved in eukaryotes and is the only known protein
containing the unusual spermidine-derived amino acid residue
hypusine [5]. Early observations of a correlation between
hypusine synthesis and cell growth suggested an important
role for hypusine in cell proliferation [5,6]. eIF5A may be a
bimodular protein interacting with both RNA and proteins and
is  presumed  to  have  an  important  role  in  the  translation
machinery  [7].  Although  eIF5A  is  intimately  involved  in
eukaryotic cell proliferation, the true physiologic function of
this essential factor has yet to be elucidated, and the potential
role of eIF5A needs further investigation.
In this report we present important results to demonstrate
that eIF5A upregulation is associated with EGF induction of
proliferation  via  phosphatidylinositol  3-kinase  (PI3-k)/
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16protein kinase B (Akt) activation. Apparently, EGF-induced
human corneal epithelial cell (HCEpiC) proliferation requires
upregulation of eIF5A to promote premature differentiation.
METHODS
Reagents used in experiments: The human corneal epithelial
cell (HCEpiC) line was obtained from the Center of China
Type  Culture  Collection  (Wuhan,  China).  Lipofectamine
2000 was purchased from Invitrogen (Carlsbad, CA). Small
interference  RNA  (siRNA)  was  synthesized  by  Wuhan
Genesil  Biotechnology  Co.,  Ltd  (Wuhan,  China).  Human
epidermal  growth  factor  (EGF;  10  ng/ml)  and  LY294002
(PI3-k inhibitor) were obtained from Sigma-Aldrich Inc. (St.
Louis,  MO).  Phototope-horseradish  peroxidase  (HRP)
western  blot  detection  system,  including  antimouse
immunoglobulin, HRP-linked antibody, biotinylated protein
ladder,  20×  LumiGLO  reagent,  and  20×  peroxide  were
purchased from Cell Signaling Technology (Beverly, MA).
The annexin V- fluorescein isothiocyanate (FITC)/propidium
iodide  flow  cytometry  assay  kit  was  purchased  from
Invitrogen.  The  antibodies  for  anti-  eukaryotic  translation
initiation  factor  5A  (eIF5A),  matrix  metallopeptidase  9
(MMP9),  proliferating  cell  nuclear  antigen  (PCNA),  anti-
phospho-Akt, and anti-total Akt antibodies were products of
Cell  Signaling  Technology.  Cell  culture  supplies  were
purchased  from  GIBCO/Life  Technologies  Inc.
(Gaithersburg, MD). The 3H-thymidine was endowed by the
isotope  laboratory  of  Nanjing  Medical  University.  Unless
otherwise  specified,  all  other  reagents  were  of  analytical
grade.
Human  corneal  epithelial  cell  line  culture  and  small
interference RNA transfection: HCEpiCs were cultured in
Dulbecco’s Modified Eagle’s Medium/Ham’s F-12 medium
(Sigma-Aldrich Inc.) containing 10% fetal bovine serum and
5 μg/ml insulin in a 37 °C incubator gassed with 5% CO2. Cells
used in experiments were from five to seven passages.
Lipofectin transfection of eIF5A siRNA was performed
according to the vendor’s protocol: 500 pmol of eIF5A siRNA
and 10 μl lipofectin were diluted in 750 μl of OptiMEM
(Gibco  BRL  Life  Technologies)  in  one  well.  After  pre-
incubation for 45 min at 37 °C, both solutions were mixed and
incubated for an additional 15 min at room temperature. The
lipofectin/eIF5A siRNA mixture was subsequently overlaid
onto the HCEpiCs and incubated for 2 h. Finally, 1 ml of
growth medium (20% fetal calf serum) per well was added for
further cultivation of the HCEpiCs.
Construction  of  eIF5A  small  interference  RNA-expressing
plasmid  vector:  In  this  experiment,  the  targeted  siRNA
sequences for eIF5A were 5′-AAC GGA ATG ACT TCC
AGC TGA-3′. Using pGenesil-1 as the vector backbone, the
vectors of eIF5A siRNA-expressing plasmid were constructed
by using green fluorescent protein (GFP) as the reporter gene.
Near the 5' end of the two oligonucleotides, a BamHI and
HindIII restriction site overhangs; a 6 nucleotide poly (T) tract
recognized as a RNA pol III termination signal is located at
the  3'  end  of  the  siRNA  template.  The  synthesized  and
annealed siRNA was ligated into the BamH1 and Hind 3 site
of the pGenesil-1 expression vector. An unrelated gene siRNA
was chosen as a negative control.
Western blot analysis: The HCEpiCs were collected with
sample  buffer  after  specific  treatments.  HCEpiCs  were
incubated in lysis buffer containing 20 mM Tris-HCl (pH 7.5),
1% Triton X-100, 1 mM ethylene diamine tetracetic acid
(EDTA), 150 mM NaCl, 10% glycerol, 1 mM Na3VO4, 50 mM
NaF,1  mM  phenylmethyl  sulfonylfluoride  (PMSF),  and
protease inhibitor for 20 min on ice. After insoluble debris was
precipitated by centrifugation at 13,000× g at 4 °C for 15 min,
the  supernatants  were  collected  and  assayed  for  protein
concentration using the Bradford method. An equal amount
of protein per sample (15 µg) was resolved on 10% sodium
dodecyl  sulfate  polyacrylamide  gel  electrophoresis  and
transferred  onto  a  polyvinylidene  fluoride  (PVDF)
membrane. The transferred membranes were blocked for 1 h
in 5% nonfat milk in PBS containing 135 mM NaCl, 2.7 mM
KCl, 1.5 mM KH2PO4, and 8 mM K2HPO4, pH 7.2, and 0.05%
Tween-20 and incubated with appropriate primary antibodies
and HRP-conjugated secondary antibodies. The protein bands
were  visualized  using  the  enhanced  chemiluminescence
western detection system.
Cell proliferation assay: HCEpiCs were plated into 96-well
plates and incubated overnight. The cultures were then serum
starved for 24 h and treated with experimental agents for
another 24 h. DNA synthesis was determined by 3H-thymidine
incorporation (3H-TdR) for the final 18 h. The media were
carefully removed and the cells detached with 50 μl trypsin-
EDTA. The cells were then harvested onto glass filters with a
Tomtech cell harvester (LKB Wallac, San Francisco, CA),
and the radioactivity retained on the dried filters was measured
by the addition of 50 ml scintillation liquid and counted in a
TopCount NxT scintillation counter (LKB Wallac).
Detection  of  apoptotic  cells:  HCEpiCs  apoptosis  were
measured  on  a  Coulter  Epics  XL  flow  cytometer  (FCM,
Beckman Coulter, Erembodegen, Belgium) with apoptosis
cells being annexin V positive/propidium iodide (PI) negative.
HCEpiCs in a 6-well plate with a density of 1×106 were
harvested and washed once with ice-cold PBS. HCEpiCs were
resuspended with binding buffer (10 mM HEPES [pH 7.4],
140 mM NaCl, 2.5 mM CaCl2) before being transferred to a
5-ml tube. Then cells were stained with 5 ml of annexin V-
FITC for 30 min and 5 ml PI (10 μg/ml) for 15 min in the dark
at room temperature. Cellular DNA was detected by FCM and
apoptosis rate was computed. Annexin V and PI staining were
yielded  equivalent  results.  Data  from  duplicates  were
averaged and used as a single representation of the percentage
of apoptotic cells for any given treatment.
Statistical analysis: Results are presented are presented as
means±standard deviation. Differences between various data
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17sets were tested for significance using the Student t test, and
p values less than 0.05 were considered significant (*p<0.05;
**p<0.01).
RESULTS
Expression  of  eIF5A  induced  by  EGF  in  HCEpiCs:  To
investigate the relationship between the effects of EGF on the
production of eIF5A in HCEpiCs, the expression of eIF5A in
HCEpiCs treated with EGF (10 ng/ml) was assessed (Figure
1A,B). The results showed that the expression of eIF5A was
significantly  increased  (p<0.01)  in  HCEpiCs  treated  with
EGF when compared with the control (medium alone). This
suggests that eIF5A may play an important role in the growth
of EGF-treated HCEpiCs.
Role  of  eIF5A  on  EGF-induced  expression  of  MMP9,
PCNA, and HCEpiC proliferation: The role of eIF5A on the
survival of EGF-treated HCEpiCs was investigated. Using
real-time PCR and western blot analysis, the expression for
MMP9 mRNA and protein was demonstrated in Figure 2A,B.
Statistically  significant  (p<0.01)  increases  compared  to
control  group  were  noted  in  the  EGF  group;  statistically
significant (p<0.01, p<0.05 respectively) changes compared
to EGF + eIF5A siRNA were noted in eIF5A siRNA and EGF
+ negative siRNA. Additionally, our analysis showed that the
expression cell cycle-associated protein PCNA mRNA and
protein  expression  in  EGF,  EGF  +  eIF5A  siRNA,  eIF5A
siRNA, EGF + negative siRNA, and medium alone group was
measured in Figure 2C,D. Statistically significant (p<0.01,
p<0.05  respectively)  differences  in  mRNA  and  protein
expression as compared to the EGF + eIF5A siRNA group
were noted in the eIF5A siRNA and EGF + negative siRNA
groups. The results of densitometric analyses demonstrated
that HCEpiCs exposed to EGF exhibited increased MMP9 and
PCNA expression when compared to the control group.
The  proliferation  of  HCEpiCs  was  assessed  by  the
changes in DNA synthesis. Figure 2E shows that EGF could
significantly upregulate DNA synthesis as compared with
medium alone. There was a 33% decrease in DNA synthesis
in HCEpiCs exposed to treatment with EGF+eIF5A siRNA
compared  to  EGF+negative  siRNA  and  an  approximately
45% decrease with eIF5A siRNA treatment compared to EGF
+eIF5A siRNA for 48 h after the initial treatment. This finding
suggests that eIF5A may play an important role in the survival
of EGF-treated HCEpiCs.
Effect  of  eIF5A  on  EGF-induced  PI3-k/Akt  activation  in
HCEpiCs: The effect of eIF5A on EGF-treated HCEpiCs may
be  involved  in  various  signaling  pathways,  but  which
signaling  pathway  plays  a  main  role  is  unclear.  In  this
experiment we focused on whether the activation of the PI3-
k/Akt  signaling  pathway  in  HCEpiCs  needed  eIF5A
stimulation. Figure 3 shows that a change in phospho-Akt
occurred after EGF, EGF+eIF5A siRNA, eIF5A siRNA, EGF
+negative siRNA, and medium alone treatment for the defined
time. The protein of phospho-Akt was increased in the EGF
group compared to the control group, and the expression of
phosphor-Akt was notably changed when compared with the
EGF+eIF5A siRNA and eIF5A siRNA groups. No differences
Figure  1.  Eukaryotic  translation
initiation factor 5A (eIF5A) expression
in  human  corneal  epithelial  cells
(HCEpiC)  was  assessed  in  this
experiment.  A:  Relative  eIF5A  gene
expression  levels  at  18  h  after
administration  of  epidermal  growth
factor  (EGF;  10  ng/ml)  and  medium
alone  (control)  was  detected  by  real-
time polymerase chain reaction (PCR).
The amplification plot of eIF5A and β-
actin  (ACTB)  are  shown.  The  graph
shows the relative eIF5A protein levels
normalized to β-actin. (**) were highly
significant when compared with control
group, in both cases p-value <0.01. B:
The expression of eIF5A protein was
measured  by  using  western  blot
analysis. The graph shows the relative
eIF5A protein levels normalized to β-
actin. Results are presented as the mean
±standard  deviation  of  three
independent  experiments  (n=3),  each
conducted in triplicate. (**) were highly
significant when compared with control
group, in both cases p-value <0.01.
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18were  noted  between  the  EGF+eIF5A  siRNA  and  EGF
+negative siRNA groups.
The  effect  of  LY294002  on  eIF5A,  MMP9,  and  PCNA
expression and HCEpiC apoptosis: In this experiment we
examined  the  effect  of  PI3-k/Akt  inhibitor  LY294002  on
eIF5A, MMP9, PCNA, and HCEpiC apoptosis by comparing
HCEpiCs treated with EGF+LY294002 to a control (EGF
alone). HCEpiCs were treated with 10 µM LY294002 (PI3-k
inhibitor) for 18 h, and cells were then stimulated with 10 ng/
ml EGF for another 24 h. Real-time PCR results showed that
treatment  with  LY294002  caused  51%,  78%,  and  29%
inhibition of eIF5A, MMP9, and PCNA mRNA expression,
respectively, when compared to the control ( Figure 4A).
Western blot results showed that LY294002 treatment caused
69%, 88%, and 65% inhibition of eIF5A, MMP9, and PCNA
protein  expression,  respectively,  when  compared  with  the
control (Figure 4B). HCEpiC apoptosis, subjected to flow
cytometric analysis, showed the least number of apoptosis
cells with EGF treatment when compared with other groups
whereas the number of apoptotic cells by treating cells with
EGF + eIF5A siRNA, EGF + eIF5A siRNA + LY294002, and
EGF  +  LY294002  considerably  increased  the  number  of
subG1 cells (Figure 4C). These results suggest that EGF-
induced HCEpiC proliferation may primarily be associated
with upregulation of eIF5A expression via activation of the
PI3-k/Akt signaling pathway.
DISCUSSION
The renewal of the corneal epithelium is a complex process
that includes the migration, proliferation, and differentiation
of epithelial cells, which maintain a healthy condition of the
corneal epithelium through a dynamic wound-healing process
[8].  This  process  is  largely  controlled  by  intercellular
signaling pathways through activation of a growth factor. Our
Figure 2. Effects of eIF5A on matrix metallopeptidase 9 (MMP9), proliferating cell nuclear antigen (PCNA), and the proliferation of HCEpiCs
were assessed in this study. Cultured HCEpiCs were treated with EGF, EGF+eIF5A siRNA, eIF5A siRNA, EGF+negative siRNA, and medium
alone (control) for the indicated times. Data were expressed by mean±SD of three independent experiments. A-B: Relative expressions of
MMP9 mRNA and protein level at 24 h after administration of different treatments were detected by real-time PCR and western blot,
respectively. The graph shows the relative eIF5A protein levels normalized to β-actin; data are expressed as mean±standard deviation (SD)
of three independent experiments. (**) were highly significant when compared with control group, in both cases p-value <0.01, asterisks
indicate p-value <0.05 with the Student t test. C-D: Relative expressions of PCNA mRNA and protein level at 36 h after administration of
different treatments were detected by real-time PCR and western blot, respectively. The graph shows the relative eIF5A protein levels
normalized to β-actin. (**) were highly significant when compared with control group, in both cases p-value <0.01, asterisks indicate p-value
<0.05 with the Student t test. E: HCEpiC proliferation at 48 h after administration of different treatments was detected by 3H-TdR. Data were
expressed as mean±SD of three independent experiments. **p<0.01 versus control group, asterisks indicate p<0.05 in t test.
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19data indicate that serum-containing growth factors, such as
EGF, stimulate corneal epithelial cell growth by upregulation
of  eIF5A  expression.  We  investigated  the  relationship
between the effects of EGF on the production of eIF5A. The
results showed that the expression of eIF5A was significantly
increased  in  HCEpiCs  treated  with  EGF  (Figure  1).  This
finding suggests that eIF5A may play an important role in the
growth of EGF-treated HCEpiCs.
eIF5A is considered a nucleocytoplasmic shuttle protein,
which is a multifunctional cellular protein expressed in a wide
range  of  tissues  and  cell  types,  including  lymphocytes,
endothelial cells, dendritic cells, and platelets [9]. Several
studies have also found a role for eIF5A involvement in cell
proliferation, and more recently it has been implicated in the
regulation of apoptosis [10]. Overexpression of eIF5A has
been found to induce hepatocellular carcinoma proliferation
[11] and skeletal stem cell differentiation [12]. To determine
whether  EGF  correlates  with  the  proliferative  activity
occurring in HCEpiC monolayers in vitro, we applied siRNA
to knock down the expression of eIF5A in corneal epithelial
cells. This is the first time this type of experiment has been
carried out. We attempted to define the migratory mechanism
of EGF-induced eIF5A expression via the MMP9 pathway.
As shown in Figure 2A,B MMP9 expression increases with
EGF treatment but significantly decreases with eIF5A siRNA
treatment.  Another  aspect  of  re-epithelialization  is  the
proliferation of epithelial cells behind the migrating wound
front.  In  our  study,  we  showed  that  PCNA  increased
expression in EGF treatment, while the expression of PCNA
treated with EGF+eIF5A negative cells was greater than in
treatment with EGF+eIF5A siRNA cells (Figure 2C,D). The
cell proliferation assay further revealed that DNA synthesis
significantly  increased  in  EGF  treatment.  A  statistically
significant increase was noted in the EGF+negative siRNA
treatment group, whereas the number of cells were lowest in
the  eIF5A  siRNA  group.  Our  results  indicate  that  EGF
promotes  corneal  epithelial  proliferation  and  induces
upregulation of eIF5A expression, which affect MMP9 and
PCNA expression, and HCEpiC proliferation.
Serum-containing  growth  factors  can  induce
transactivation of receptor tyrosine kinases and activate the
PI3-k/Akt signaling pathway [13]. PI3-k is a heterodimeric
cytoplasmic enzyme that physically associates with tyrosine-
phosphorylated membrane-bound cellular proteins via the Src
homology  2  (SH2)  domain  of  itself  (85  kDa  regulatory
subunit).  Akt  is  one  of  the  PI3-k  effectors  that  play  an
important role in mediating transformation and anti-apoptotic
effects [14,15]. These findings lead to the hypothesis that
translocation  and  membrane  localization  of  PI3-k  are
necessary for its activation in vivo. Several other studies have
Figure 3. The effect of eIF5A treatment
on phosphorylation of protein kinase B
(Akt) in HCEpiC was detected in this
experiment.  Western  blot  analyses  of
phospho-Akt  in  EGF,  EGF+eIF5A
small  interference  RNA  (siRNA),
eIF5A  siRNA,  EGF+negative  siRNA,
and  medium  alone  (control)-treated
cells. At 48 h post infection, HCEpiCs
were stimulated with EGF. After further
incubation  for  30  min,  cells  were
subjected to western blot analysis. The
graph shows the relative phospho-Akt
protein levels normalized to total-Akt.
(**)  were  highly  significant  when
compared with control group, in both
cases p-value <0.01, asterisks indicate
p-value < 0.05 with the Student t test.
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20also reported that PI3-k/Akt has a positive role in the EGF-
induced proliferation of corneal epithelial cells [16]. Our data
show that EGF can activate the PI3-k/Akt signal transduction
pathway, but the expression of p*-Akt protein does not appear
to change between EGF+negative siRNA and EGF+eIF5A
siRNA groups. Since eIF5A has no effect on the expression
of p*-Akt (Figure 3), we conclude that the PI3-k/Akt signaling
pathway is downstream for EGF but not for eIF5A.
Further studies are being performed to understand how
the PI3-k/Akt signaling pathway is involved in EGF-induced
corneal epithelial cell proliferation. Figure 4A,B shows that
pretreatment with LY294002 inhibits the expression level of
eIF5A, MMP9, and PCNA, suggesting that eIF5A, MMP9,
and PCNA are possible substrates for the PI3-k/Akt signaling
pathway in EGF-induced HCEpiC proliferation. Moreover,
our data indicate that synergistic treatment with eIF5A siRNA
and  LY294002  significantly  increases  apoptotic  HCEpiC
death.
In summary, we have demonstrated for the first time that
EGF  induces  HCEpiC  proliferation  via  upregulation  of
eIF5A expression. The effect of eIF5A is accomplished in
corneal epithelial cells through activation of the PI3-k/Akt
signaling pathway, suggesting that upregulation of eIF5A is
importance for EGF to elicit control of corneal epithelial cell
growth and fate.
Figure 4. eIF5A, MMP9, and PCNA expression in HCEpiCs treated with EGF (control) or EGF+LY294002 were assessed in this experiment.
A: eIF5A, MMP9, and PCNA gene expression was detected by real-time PCR. The graph shows the relative eIF5A, MMP9, and PCNA mRNA
levels normalized to ACTB. **p<0.01 versus control group, ***p<0.001 versus control group. B: The expression of eIF5A, MMP9, and PCNA
protein was measured by using western blot analysis. The graph shows the relative eIF5A, MMP9, and PCNA protein levels normalized to
β-actin. Results are presented as the mean±standard deviation of three independent experiments (n=3), each conducted in triplicate. (**) were
highly significant when compared with control group, in both cases p-value < 0.01, three asterisks indicate p-value < 0.001 with the Student
t test. C: HCEpiCs were treated with EGF, EGF+eIF5A siRNA, EGF+eIF5A siRNA+LY294002, and EGF+LY294002. HCEpiCs were treated
with 10 µM LY294002 (PI3-k inhibitor) for 18 h; at 48 h post infection, cells were stimulated with EGF. After further incubation for 18 h,
cells were subjected to flow cytometric analysis.
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